Karyopharm to present at the jefferies global healthcare conference

Newton, mass. , june 3, 2025 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the company's senior management team is scheduled to present at the jefferies global healthcare conference on thursday, june 5, 2025 at 3:10 p.m.

KPTI Ratings Summary

KPTI Quant Ranking